SonALAsense

Son Al Asense

Biotechnology, 2600 10th St Ste 435, Berkeley, California, 94710, United States, 1-10 Employees

sonalasense.com

  • twitter
  • LinkedIn

phone no Phone Number: 51********

Who is SONALASENSE

SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma mult...

Read More

map
  • 2600 10th St Ste 435, Berkeley, California, 94710, United States Headquarters: 2600 10th St Ste 435, Berkeley, California, 94710, United States
  • 2019 Date Founded: 2019
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SONALASENSE

SonALAsense Org Chart and Mapping

Employees

Stuart Marcus

Founder and Chief Scientific Officer

Sam Zenhari

Director, Clinical Operations

Ryan Clanton

Director of Device Development

Corina Andresen

Vice President Clinical Development, Oncology, Sonalasense

Chandler Coate

Clinical Trial Assistant

Nandini Kandolha

Chief Financial Officer & Chief Operations Officer

Sudheer Swamy

Director, Project Management

Lenora Henry

Manager of Device Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding SonALAsense

Answer: SonALAsense's headquarters are located at 2600 10th St Ste 435, Berkeley, California, 94710, United States

Answer: SonALAsense's phone number is 51********

Answer: SonALAsense's official website is https://sonalasense.com

Answer: SonALAsense's revenue is Under $1 Million

Answer: SonALAsense's SIC: 2836

Answer: SonALAsense's NAICS: 541714

Answer: SonALAsense has 1-10 employees

Answer: SonALAsense is in Biotechnology

Answer: SonALAsense contact info: Phone number: 51******** Website: https://sonalasense.com

Answer: SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access